History
PepTcell is a young biotechnology company that began operating in 2004, with the aim of converting theoretical concepts into novel analytical tools and clinical products, in the field of immunology.
Indeed, the founding shareholders and key employees have been working on these concepts for 20 years. Since the company began it has focused on developing and completing the software and algorithms for its new analytical tools, the filing of patents, establishing collaborations with research groups to test several of its candidate drug products independently, progressing the majority of its pre-clinical work for its influenza and HIV vaccines and successfully raising capital from a range of investors.